DNA Sequencing Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Rise in Burden of Chronic Diseases & Shortage of Healthcare Workers
   3. Market Restraints
      1. Regulatory and Compliance Challenges
      2. High Operational Costs and Margin Pressure
   4. Market Opportunity
      1. Increasing Number of Healthcare Facilities
   5. Market Trends
      1. Adoption of Advanced Recruitment Technologies
      2. Growth of Telehealth and Remote Staffing Solutions
5. MARKET SEGMENTATION
   1. By Product & Services
      1. Consumables
      2. Instruments
      3. Services
   2. By Technology
      1. Sanger Sequencing
      2. Next-Generation Sequencing
         1. Whole Genome Sequencing (WGS)
         2. Whole Exome Sequencing (WES)
         3. Targeted Sequencing & Resequencing
      3. Third Generation DNA Sequencing
         1. Single-Molecule Real-Time Sequencing (SMRT)
         2. Nanopore Sequencing
   3. By Workflow
      1. Pre-sequencing
      2. Sequencing
      3. Data Analysis
   4. By Application
      1. Oncology
      2. Reproductive Health
      3. Clinical Investigation
      4. Agrigenomics & Forensics
      5. HLA Typing/Immune System Monitoring
      6. Metagenomics, Epidemiology & Drug Development
      7. Consumer Genomics
      8. Others
   5. By End-Use
      1. Academic Research
      2. Clinical Research
      3. Hospitals & Clinics
      4. Pharmaceutical & Biotechnology Companies
      5. Other Users
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Agilent Technology
      2. BGI
      3. Bio-Rad Laboratories, Inc.
      4. Eurofins Scientific
      5. F. Hoffmann-La Roche Ltd.
      6. Illumina, Inc.
      7. Myriad Genetics
      8. QIAGEN
      9. Macrogen, Inc.
      10. PerkinElmer Genomics
      11. PacBio
      12. PierianDx
      13. Partek Incorporated
      14. Thermo Fisher Scientific, Inc
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global DNA Sequencing market?

The global market of DNA sequencing is projected to reach USD 65.52Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global DNA Sequencing market?

The global DNA sequencingmarket has an estimated annual growth rate of 18.5%.

Q.3. What are the recent trends of DNA Sequencing market?

Integration of artificial intelligence and machine learningand expansion of point-of-care sequencing solutionsare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in DNA Sequencing?

The major companies profiled in this report include Agilent Technology, BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., Myriad Genetics, QIAGEN, Macrogen, Inc., PerkinElmer Genomics, PacBio, PierianDx, Partek Incorporated, Thermo Fisher Scientific, Inc, among others.  

Q.5. Which is the largest regional market in the DNA Sequencing?

North America is the largest regional market for DNA sequencing.